ArticleArthritis research & therapy2025

Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway.

Zhiping Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.